Abiopharma

New Form S-8 - ClearPoint Neuro, Inc. Filed: 2025-09-04 AccNo: 0001285550-25-000014 Size: 466 KB

Die Designed Enzymatic Biomaterials™-Plattform von IFF wird erstmals in großem Maßstab in der Haushaltspflege eingesetzt

iSpecimen Approached by Crypto Currency Companies for $200 Million Treasury Discussions

New Form 144 - INTUITIVE SURGICAL INC Filed: 2025-09-04 AccNo: 0001950047-25-006732 Size: 5 KB

ClearPoint Neuro Announces FDA Clearance Expanding Compatibility of the ClearPoint Prism Neuro Laser Therapy System with 1.5T MRI Scanners

Hungerford Brian 🟢 acquired 100.0K shares (1 derivative) of Aspira Women's Health Inc. (AWHL) at $0.41 Transaction Date: Sep 02, 2025 | Filing ID: 026580

Phreesia Investor Relations - Phreesia to Acquire AccessOne, Expanding Its Suite of Payment Solutions

Director Errico Thomas J. 🟢 acquired 26.6K shares of electroCore, Inc. (ECOR) Transaction Date: Sep 02, 2025 | Filing ID: 012634

Lifecore Biomedical to Participate at 24th Annual Contract Pharma Contracting and Outsourcing Conference

STRATA Skin Sciences Announces Closing of $2.42 Million Registered Direct Offering

Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)

Regeneron Announces Updated Presentation Time for Upcoming Investor Conference

Zimmer Biomet to Showcase Foot and Ankle Portfolio at the American Orthopedic Foot and Ankle Society Annual Conference

Denton Sheila A. 🟡 adjusted position in 598 shares (1 derivative) of INCYTE CORP (INCY) at $84.97 Transaction Date: Sep 02, 2025 | Filing ID: 000004

AMGEN TO PRESENT AT THE MORGAN STANLEY 23RD ANNUAL GLOBAL HEALTHCARE CONFERENCE